Celltrion of S Korea receives US emergency approval for rapid test Sampinute

Celltrion of S Korea receives US emergency approval for rapid test Sampinute

By Anna Domanska - Oct 26, 2020

South Korean biopharma company has got emergency use approval (EUA) from the US authorities for its rapid test Sampinute that has an accuracy rate of 94% and a turnaround time of 1

Read More